Targeson Inc. is a molecular imaging company focused on developing targeted ultrasound imaging agents to detect and monitor serious diseases. Molecular imaging improves detection of disease even before the onset of clinical symptoms, and can monitor response to therapeutic treatment. The company’s technology is based on proprietary acoustically active microspheres, which enable researchers to identify… Read More